Viewing StudyNCT00127881

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 11:46 AM
Last Modification Date: 2024-10-26 @ 9:13 AM
Study NCT ID: NCT00127881
Status: TERMINATED
Last Update Posted: 2012-07-26
First Post: 2005-08-08
Brief Title: Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome
Sponsor: Emergent Product Development Seattle LLC
Organization: Emergent Product Development Seattle LLC
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Sezary Syndrome
Mycosis Fungoides
Keywords:
Name View
To evaluate the efficacy and safety of zanolimumab in Mycosis Fungoides and sezary syndrome View
Refractory or intolerant to Mycosis Fungoides and sezary syndrome View
Cutaneous T-cell Lymphoma View